Kamada Plasma is a leading brand that specializes in the collection of hyperimmune human plasma. They are one of the few specialty plasma collection centers in the United States. With FDA licensure and certifications from the Plasma Protein Therapeutics Association (PPTA) and Clinical Laboratory Improvement Amendments (CLIA), Kamada Plasma ensures the highest standards of quality and safety.

As a wholly owned subsidiary of Kamada Ltd., Kamada Plasma aims to become a fully integrated specialty plasma company. They plan to expand their plasma collection capabilities by investing in their current center and leveraging their FDA license to open additional centers across the US. Kamada Plasma's collection facility primarily focuses on gathering hyperimmune plasma used in the production of vital medical treatments.

This includes Anti (D) immunoglobulin for preventing Hemolytic disease of the newborn, which occurs due to Rh factor mismatches between mother and child. They also collect hyperimmune plasma for manufacturing Rabies immunoglobulin, used in the treatment of individuals exposed to rabid animals. In addition, Kamada Plasma collects specialty products from rare donors.

These products are used to create blood typing reagents, diagnostic test kits for various diseases, and for valuable research purposes. To learn more about how you can contribute and make a difference, please fill out their contact form on their website. Kamada Plasma is dedicated to making a positive impact on healthcare and saving lives through their vital plasma collection efforts.

Visit www. kamada. com to learn more